HOME >> BIOLOGY >> NEWS
JCI table of contents: November 23 2005

Immunological karma: T cells reactive to old flu infections make unrelated viral infections worse
Childhood infection with Epstein-Barr virus (EBV) is often asymptomatic, while the same infection in adolescents and adults causes infectious mononucleosis (IM). Liisa Selin and colleagues from the University of Massachusetts Medical School now show how, in a strange twist of immunological karma, T cells specific to a previously encountered virus (such as the flu) may come back to haunt you, by overzealously responding to a subsequent, unrelated viral infection like EBV, thereby increasing the severity of the immune response and causing IM. Their results appear online on November 23 in advance of print publication in the December issue of the Journal of Clinical Investigation.

The authors found that, in patients with IM, memory CD8+ T cells specific to an epitope of the influenza virus encountered in a previous infection, also recognized and reacted to an epitope of the Epstein-Barr virus. These two epitopes, with only 33% similarity, stimulate different T cell activities, which in sum skew the immune response to EBV infection. Excessive lymphocyte proliferation contributes to the marked deviation in disease course and is symptomatic of IM.

Overall, this demonstration of cross-reactivity involving 2 immunodominant epitopes from 2 of the most common human viruses highlights the potential importance of cross-reactive T cells in human disease states.

TITLE: Cross-reactive influenza virusspecific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virusassociated infectious mononucleosis

AUTHOR CONTACT:
Liisa Selin
University of Massachusetts Medical School, Worcester, Massachusetts, USA
Phone: 508-856-3039
Fax: 508-856-0019
E-mail: liisa.selin@umassmed.edu

View the PDF of this article at:

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
23-Nov-2005


Page: 1 2 3 4 5

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... Today, Mediaplanet announces the ... innovative work being done within rare diseases research, diagnostics, and will highlight what ... rare diseases. , The print component of "Rare Diseases" is ...
(Date:9/12/2018)... Minn. (PRWEB) , ... September 11, 2018 , ... ... wall coatings, is proud to introduce the new ChemXP™ line of high performance ... environments. The line was developed to provide Tennant Coatings’ elite certified installers with ...
(Date:9/12/2018)... ... 12, 2018 , ... Captiva Spine, Inc., which designs, manufactures ... 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market TowerLOX-EXT® ... TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the narrow insertion of an extended ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on ... meeting of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high ... to study these emerging targets in a quest to find new treatments for ...
(Date:8/31/2018)... ... 2018 , ... A recent expedition led by Dr. Blair ... of Industrial Science, the University of Tokyo, demonstrated how the use of autonomous ... of hard to reach deep sea ecosystems, like intermittently active methane seeps. Thanks ...
(Date:8/29/2018)... ... 2018 , ... CEO and founder of VetStem Biopharma, Dr. ... an allogeneic (donor derived) stem cell product for osteoarthritis in canines at the ... He is also the organizer of Breakout Session 4: Practitioner Primer on FDA ...
(Date:8/23/2018)... RENO/TAHOE, Nev. (PRWEB) , ... August 22, 2018 ... ... TrialKit ™ for Android on September 1st, making it the first fully-featured ... both iOS and Android devices. Combined, iOS and Android constitute 99 percent of ...
Breaking Biology Technology:
Cached News: